A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

PASI score is a measure of the level of severity. It stands for Psoriasis Area Severity Index. It looks at 3 dimensions, erythema, induration, and scaling or discrimination.

When using PASI, healthcare professionals should take into account skin colour and how this could affect the PASI score, and make the clinical adjustments they consider appropriate. The ...

Patients treated with orismilast 20 mg, 30 mg or 40 mg had a –52.6%, –61.2% and –63.7% change in PASI score, respectively, compared with –17.3% in those treated with placebo at week 16 ...

A PASI 90 score signifies that 90% of skin surface area is cleared. The proportion of patients who achieved a PASI 100 score, signifying total clearance, approached 70% at 4 years in the group ...

1.1 Brodalumab is recommended as an option for treating plaque psoriasis in adults, only if: 1.3 When using the PASI, healthcare professionals should take into account skin colour and how this could ...